This study evaluates the safety, tolerability, and biomarker effects of twice-daily topical delgocitinib 2% cream in adults with lichen planopilaris (LPP) or c…

Central Centrifugal Cicatricial AlopeciaLichen Planopilaris

~Estimated

~$10 – $6,250

Icahn School of Medicine at Mount SinaiNCT07487948

Phase 2

A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults With Lichen Planopilaris

This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with lichen planopilaris

Lichen Planopilaris

~Estimated

~$10 – $8,750

Priovant Therapeutics, Inc.NCT07532603